When it goes down to $0.99, you should get it. That'll probably happen during Gameloft's winter holiday sale. The campaign is a lot of fun, but sadly only lasts 2-3 hours. You're not going to enjoy the multiplayer at all.
Gameloft always go on sale during holidays, so just wait for them to hold another one of their famous sales if your considering a gameloft game.
imo, the multiplayer isnt bad, but it can get laggy. However, I have the same problems with MC3 so...
For anyone looking to pick up the Bard's tale, get it now!!! It will be going up to $10 in a couple of weeks!!! If you want a premium game, pay a premium price.
Or don't get it now, and pay the full price for an awesome game. PS: That Gamecenter bug is really making me annoyed though.
Haha yeah, but I know most won't want to wait to play this! Yeah the bug is very annoying. I'm putting playing the game on hold because I have an ADD-I completionist personality.
Considering I keep hearing CoD:BOZ is worse than the previous Zombies, and IB2 is better than IB... I'd go with Infinity Blade.
First things first, I have a 32gig Ipod Touch 4th gen. With that being said, which should I get? Infinity Blade II or The Bard's Tale I have beaten IB many times and am dying to play IB2 but the bugs are worrying me. At the same time, I see The Bard's Tale waving his hand at me like he's saying, "Hey, over here!!!"
If you're planning on getting both eventually, I'd go with Bard's Tale first since it'll go up to $9.99 after a week or two like it says a few posts ago.
Yep, you get full functionality of the Tetris you know and love without any extra purchases. I still don't like that the IAP's are there at all, but they're definitely not required.
Between IB2, The Bard's Tale, and Black Ops Zombies, the latter is definitely the worst buy. Really hard choice between The Bard's Tale and IB2 though. One's a long, immersive RPG experience while the other is a fighter with killer visuals that you can play in short bursts. Still haven't voted for GOTW yet since I can't decide, lol.
